Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyo…
$1.97-6.86%
报价 2026-11-16
市值
$166.4M
EV
$226.9M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -53.2%
$1.39$4.21
筛选结果
pipeline · 2026-11-16Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| ELDNEledon Pharmaceuticals, Inc. | $166.4M | -6.9% | -100.0% | 0% | – | – | – | |
| PBYIPuma Biotechnology, Inc. | $379.5M | -5.5% | +2.0% | 74.5% | 10.1x | 5.4x | 26.3x | |
| AVIRAtea Pharmaceuticals, Inc. | $330.9M | -4.2% | -19.7% | 0% | – | – | – | |
| EDITEditas Medicine, Inc. | $288.6M | -13.8% | +27.8% | 56.9% | – | – | – | |
| ALLOAllogene Therapeutics, Inc. | $279.6M | -3.8% | +1.3% | 0% | – | – | – | |
| VNDAVanda Pharmaceuticals Inc. | $230.4M | -4.5% | +20.3% | 93.2% | – | – | – | |
| TRDAEntrada Therapeutics, Inc. | $195.8M | -1.8% | -36.1% | 57.5% | – | – | – | |
| HUMAHumacyte, Inc. | $150.1M | -3.2% | +174.1% | -533% | – | – | – | |
| ABEOAbeona Therapeutics Inc. | $148.6M | +7.4% | +1241.7% | 26.3% | 3.3x | – | – | |
| 同行中位数 | – | – | +11.2% | 41.6% | 6.7x | 5.4x | 26.3x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。